RYBREVANT (amivantamab-vmjw)
ANTINEOPLASTIC - BISPECIFIC EGFR AND MET REC INHIBITOR MC AB · NON-SMALL CELL LUNG CANCER WITH EGFR EXON 19 DELETION ·+2
JANSSEN BIOTECH, Inc.